Erste Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $169K | Hold |
|
|||||
|
2025
Q1 | $195K | Hold |
|
|||||
|
2024
Q4 | $248K | Hold |
|
|||||
|
2024
Q3 | $234K | Hold |
|
|||||
|
2024
Q2 | $254K | Hold |
|
|||||
|
2024
Q1 | $341K | Hold |
|
|||||
|
2023
Q4 | $355K | Hold |
|
|||||
|
2023
Q3 | $260K | Hold |
|
|||||
|
2023
Q2 | $247K | Hold |
|
|||||
|
2023
Q1 | $216K | Hold |
|
|||||
|
2022
Q4 | $257K | Hold |
|
|||||
|
2022
Q3 | $360K | Hold |
|
|||||
|
2022
Q2 | $270K | Hold |
|
|||||
|
2022
Q1 | $239K | Buy |
|